Tata Elxsi Ltd
Tata Elxsi Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Confident of stronger growth in H2 compared to H1, with margin recovery expected as utilization targets (from 70% to 75%) are met. Management is confident that growth in H2 FY '26 will be significantly better than H1, driven by strong pipelines and deal ramp-ups, especially in automotive and healthcare sectors.
From Tata Elxsi Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Confident of stronger growth in H2 compared to H1, with margin recovery expected as utilization targets (from 70% to 75%) are met.
- Automotive segment expected to achieve double-digit growth in FY '27, driven by ramp-up in deals and improved client discussions; Europe and Japan showing positive traction, U.S. slightly muted but adjacency segments growing.
- Healthcare anticipated to deliver double-digit growth next financial year supported by new deals and strong pipeline development.
- Media & Communication sector likely to see moderated growth in H2 given industry volatility and deal ramp-ups, with cautious outlook on achieving double-digit growth.
2 more points from Tata Elxsi Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Tata Elxsi Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Tata Elxsi has not added significant new capital expenditure recently; current capacity is well managed.
- Depreciation is declining due to lack of major new capex additions.
- The company expects to maintain current capacity for at least a few more quarters before any additional infrastructure development is required.
2 more points from Tata Elxsi Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Tata Elxsi Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Tata Elxsi reported a robust pipeline momentum driven by global OEM Software-Defined Vehicle (SDV) programs and other large deal wins.
- The company has seen strong deal wins and ramp-ups, especially in automotive, healthcare, and adjacent sectors like aerospace and defense.
- The healthcare pipeline is building with new customers and large deals across key regions.
- The system integration business has grown strongly, supported by awards like the one from Dell Technologies, highlighting next-gen infrastructure capabilities.
2 more points from Tata Elxsi Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Tata Elxsi Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹994 Cr, net profit ₹220 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tata Elxsi's management said in earlier quarters
Arthneeti Pro · Annual
Tata Elxsi Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Tata Elxsi Ltd Q2 FY26 results?
Confident of stronger growth in H2 compared to H1, with margin recovery expected as utilization targets (from 70% to 75%) are met. Management is confident that growth in H2 FY '26 will be significantly better than H1, driven by strong pipelines and deal ramp-ups, especially in automotive and healthcare sectors.
What is Tata Elxsi Ltd share price analysis?
Tata Elxsi Ltd currently shows a neutral. The stock trades at a P/E of 34.0 with a market cap of ₹23,988 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tata Elxsi Ltd planning capital expenditure?
Tata Elxsi has not added significant new capital expenditure recently; current capacity is well managed.
Keep Tata Elxsi Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.